- Home
- OLP vs PHAR Comparison
OLP vs PHAR Comparison
Compare OLP & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- PHAR
- Stock Information
- Founded
- OLP 1982
- PHAR 1988
- Country
- OLP United States
- PHAR Netherlands
- Employees
- OLP N/A
- PHAR N/A
- Industry
- OLP Real Estate Investment Trusts
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- PHAR Health Care
- Exchange
- OLP Nasdaq
- PHAR Nasdaq
- Market Cap
- OLP N/A
- PHAR 618.3M
- IPO Year
- OLP N/A
- PHAR N/A
- Fundamental
- Price
- OLP $25.92
- PHAR $8.42
- Analyst Decision
- OLP Strong Buy
- PHAR Strong Buy
- Analyst Count
- OLP 1
- PHAR 3
- Target Price
- OLP $28.00
- PHAR $27.00
- AVG Volume (30 Days)
- OLP 46.6K
- PHAR 5.6K
- Earning Date
- OLP 03-04-2025
- PHAR 03-13-2025
- Dividend Yield
- OLP 7.06%
- PHAR N/A
- EPS Growth
- OLP 51.11
- PHAR N/A
- EPS
- OLP 1.63
- PHAR N/A
- Revenue
- OLP $89,142,000.00
- PHAR $285,745,000.00
- Revenue This Year
- OLP N/A
- PHAR $20.08
- Revenue Next Year
- OLP $4.71
- PHAR $9.22
- P/E Ratio
- OLP $15.65
- PHAR N/A
- Revenue Growth
- OLP N/A
- PHAR 30.64
- 52 Week Low
- OLP $19.75
- PHAR $6.65
- 52 Week High
- OLP $30.45
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- OLP 45.92
- PHAR 40.05
- Support Level
- OLP $25.27
- PHAR $7.95
- Resistance Level
- OLP $25.93
- PHAR $9.35
- Average True Range (ATR)
- OLP 0.50
- PHAR 0.52
- MACD
- OLP 0.12
- PHAR -0.16
- Stochastic Oscillator
- OLP 71.79
- PHAR 22.76
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.